ICSE, International Contract Services Expo, is an unique opportunity to present new products, outsourcing solutions or R&D development to the Japanese pharmaceutical audience.
Held alongside CPhI Japan, ICSE Japan connects the pharmaceutical community who are keen to capitalize on the benefits of doing business in Japan. Besides contract manufacturing and contract research, other main services provided are packaging, clinical trials, laboratory services, drug discovery, logistics and marketing services. No matter what your function within the biotechnology or pharmaceutical industry is, ICSE will show you how your organization can benefit from outsourcing to Japan and enable you to arrange it. ICSE Japan connects the pharmaceutical community with diverse outsourcing solutions such as: clinical trials, contract manufacturing, contract research, packaging, logistics or analytical services. Find a broad range of products with the latest developments and meet the company representatives in person.
Owned by UBM plc listed on the London Stock Exchange, UBM Asia operates in 19 market sectors with headquarters in Hong Kong and subsidiary companies across Asia and in the US. We have over 280 products including trade fairs, conferences, trade publications, B2B/B2C portals and virtual event services. As Asia's leading exhibition organiser and the biggest commercial organiser in China, India and Malaysia, we stage the leading events of their kind across Asia. Our 200 events, 28 publications and 18 vertical portals serve a 1,000,000 quality exhibitors, visitors, conference delegates, advertisers and subscribers from all over the world with high value face-to-face business-matching events, quality and instant market news on market and industry trends and round-the-clock online trading networks and sourcing platforms. We have 1,200 staff in 25 major cities across Asia, stretching from Japan to Turkey.